title: Safety of rapid subcutaneous gammaglobulin infusions in patients with primary antibody deficiency.
authors.affiliation: Dept. of Clinical Immunology, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden.
authors.forename: A
authors.initials: A
authors.lastname: Gardulf
authors.forename: H
authors.initials: H
authors.lastname: Björvell
authors.forename: R
authors.initials: R
authors.lastname: Gustafson
authors.forename: L
authors.initials: L
authors.lastname: Hammarström
authors.forename: C I
authors.initials: CI
authors.lastname: Smith
mesh_terms: D000293:Adolescent; D000328:Adult; D000361:Agammaglobulinemia / Q000628:therapy; D000368:Aged; D005260:Female; D006801:Humans; D017098:IgA Deficiency / Q000628:therapy; D017099:IgG Deficiency / Q000628:therapy; D007153:Immunologic Deficiency Syndromes / Q000628:therapy*; D007263:Infusions, Parenteral; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D012449:Safety; D012646:Self Administration; D005719:gamma-Globulins / Q000008:administration & dosage* / Q000009:adverse effects*
chemical_list: D005719:gamma-Globulins